Project Grant HT94252410336
- Federal Grant Award Summary The Bronx Veterans Medical Research Foundation, Inc. (BVMRF) received a $1.96 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 15, 2025, with completion targeted for September 14, 2029. The award funds a multimodal molecular study investigating the active pathophysiological pathways of blast injury and neurotrauma in military tactical training operations. This...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Bronx Veterans Medical Research Foundation, Inc. (BVMRF) a Project Grant totaling $1,499,912 under the Military Medical Research and Development program (CFDA 12.420), effective June 1, 2025, through May 31, 2028. The primary deliverable under this award is a clinical research study investigating the safety, tolerability, and outcomes of psilocybin treatment in veterans with spinal cord injury. This research...
- The Department of the Army Medical Command awarded a $520,751 Project Grant to the Veteran Research And Education Foundation Of ST Louis through the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from August 1, 2022 to July 31, 2026 to improve outcomes for prostate cancer patients based on comorbidities, with the goal of developing personalized medicine approaches. Through this award, the Foundation will conduct research to investigate medical...
- The U.S. Defense Health Agency awarded a $2,916,605 Project Grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to the Boston VA Research Institute, Inc. (BVARI) on September 30, 2023. The 4-year award, titled "LONG-TERM PSYCHOLOGICAL AND PHYSICAL HEALTH OUTCOMES FOLLOWING MILITARY DEPLOYMENT: THE VETERANS AFTER-DISCHARGE LONGITUDINAL REGISTRY (PROJECT VALOR)", will fund BVARI's research to investigate risk factors, prevention, and...
- Grant Award Summary The Arizona Veterans Research And Education Foundation received a $1,029,002 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the identification of recessive prostate cancer risk alleles. The three-year award period runs from September 1, 2025, through August 31, 2028. This project contributes to the DHA's broader mission of transforming healthcare for military service...
- The Department of the Army Medical Command awarded Beth Israel Deaconess Medical Center, Inc. (BIDMC) a $1.3 million Project Grant over four years from July 2021 to June 2025 under the Military Medical Research and Development program (CFDA 12.420). The grant will fund BIDMC's research project "BH3 MIMETIC DRUGS FOR PROSTATE CANCER THERAPY." Through this funding, BIDMC researchers will investigate medical solutions for prostate cancer by developing BH3 mimetic drugs to transform...
- The Defense Health Agency awarded a $1,493,220 Project Grant to The Cleveland VA Medical Research & Education Foundation under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a "Neurally Integrated Lower Limb Prosthesis for Home and Community Use" to aid mobility and sensory restoration for wounded veterans. The 4-year project, running from September 2023 to August 2027, aligns with the program's priorities of advancing...
- Federal Grant Award Summary H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. received a $459,360 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct research on genetic risk factors associated with prostate cancer in self-identified Black veterans. The three-year award, which commenced July 1, 2025 and concludes June 30, 2028, supports hypothesis-driven biomedical research aimed at advancing...
- The Defense Health Agency awarded a $6,325,327 project grant to the Tampa VA Research and Education Foundation, Inc. under the Military Medical Research and Development program (CFDA 12.420) to improve health care access and engagement for veterans and service members with traumatic brain injury morbidity over a 4-year period ending on September 29, 2027. As the prime grantee, the foundation will provide data identification, extraction, natural language processing, and data transformation...
- The Defense Health Agency awarded a $462,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Albert Einstein College of Medicine in Bronx, NY. This grant, with a period of performance from January 1, 2025 to December 31, 2026, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the grant will fund research on the "Proteomics of Vascular Wall...
The Bronx Veterans Medical Research Foundation, Inc. (BVMRF) was awarded a $339,855 federal Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant funding supports a 3-year research project titled "DATA SCIENCE APPROACHES TO PREDICT AND UNDERSTAND SIDE EFFECTS OF ANDROGEN DEPRIVATION THERAPY IN VETERANS WITH PROSTATE CANCER UNDERGOING LONG-TERM TREATMENT." This research aims to utilize data science methods to better predict and understand the side effects experienced by veterans with prostate cancer who undergo long-term androgen deprivation therapy. As a non-profit organization focused on medical research for veterans, BVMRF will leverage its expertise and collaborations to conduct this study, which has the potential to improve care and outcomes for the veteran population affected by prostate cancer and its treatments.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $339.9k | 4/11/24 |